NX-07

N/A

Report date: 2022/06/22 13:56:30

Base Information

Drug NameNX-07
Drug Alias NameNX-07
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionPlatelet aggregation inhibitors
TargetsUpdating
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZhuangya (Beijing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuangya (Beijing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A